Rad GTPase inhibits the NFκB pathway through interacting with RelA/p65 to impede its DNA binding and target gene transactivation

• Published in: Cellular signalling 2014-07, Vol.26 (7), p.1437-1444
• Main Authors: Hsiao, Bo-Yuan, Chang, Tsun-Kai, Wu, I-Ting, Chen, Mei-Yu
• Format: Article
• Language: English
• Subjects: 14-3-3 Proteins - biosynthesis; Arrays; Assaying; Binding; Cancer; Cell Line, Tumor; Cell Nucleus - metabolism; Deoxyribonucleic acid; Depletion; DNA-Binding Proteins - metabolism; Electrophoretic Mobility Shift Assay; Genes; GTPase; Humans; I-kappa B Kinase - metabolism; Lung Neoplasms - genetics; Lung Neoplasms - pathology; Matrix Metalloproteinase 9 - biosynthesis; Neoplasm Invasiveness - genetics; NFκB; Pathways; Protein Binding; Rad; ras Proteins - biosynthesis; ras Proteins - genetics; ras Proteins - metabolism; RelA/p65; Response Elements - genetics; RNA Interference; RNA, Small Interfering; TNFα; Transcription Factor RelA - biosynthesis; Transcription Factor RelA - metabolism; Transcriptional Activation; Tumor Necrosis Factor-alpha - metabolism
• ISSN: 0898-6568; 1873-3913
• DOI: 10.1016/j.cellsig.2014.03.003

Rad is a Ras-related small GTPase shown to inhibit cancer cell migration, and its expression is frequently lost in lung cancer cells. Here we provide evidence that Rad can negatively regulate the NFκB pathway. Overexpressing Rad in cells lowered both the basal and TNFα-stimulated transcriptional activity of NFκB. Compared with control cells, Rad-overexpressing cells displayed more cytoplasmic distribution of the NFκB subunit RelA/p65, while Rad-knockdown cells had higher levels of nuclear RelA/p65. Depleting Rad did not affect the kinetics of TNFα-induced IκB degradation, suggesting that Rad-mediated regulation of NFκB was through an IκB-independent mechanism. Expression of a nucleus-localized mutant Rad was sufficient to inhibit the NFκB transcriptional activity, whereas expressing the scaffolding protein 14-3-3γ to retain Rad in the cytoplasm alleviated the suppressive effect of Rad on NFκB. GST pull-down assays showed that Rad could directly bind to RelA/p65, and co-immunoprecipitation demonstrated that the Rad–p65 interaction primarily occurred in the nucleus. Adding Rad-containing nuclear extracts or purified GST-Rad in the electrophoretic mobility shift assays dose-dependently decreased the binding of RelA/p65 to an oligonucleotide probe containing the NFκB response element, suggesting that Rad may directly impede the interaction between RelA/p65 and DNA. Rad depletion altered the expression of an array of NFκB target genes, including upregulating MMP9. Knockdown of Rad expression in cells increased both basal and TNFα-stimulated MMP9 activities and cell invasion. Collectively, our results disclose a novel role of nuclear Rad in inhibiting the NFκB pathway function. [Display omitted] •Rad inhibits basal and TNFα-stimulated transcriptional activity of NFκB.•Rad binds to the NFκB subunit RelA/p65 primarily in the nucleus.•Rad decreases the binding of RelA/p65 to κB DNA response elements.•Depletion of Rad alters the expression of an array of NFκB target genes.•Knockdown of Rad increases TNFα-stimulated cancer cell invasiveness.